10-Q: iCoreConnect Inc. Reports 48% Revenue Increase in Q1 2024, But Losses Widen

iCoreConnect Inc. saw a significant revenue increase of 48% in the first quarter of 2024, driven by organic growth and recent acquisitions, but also experienced a substantial net loss.

Summary

• iCoreConnect Inc. reported a 48% increase in revenue for the first quarter of 2024, reaching $2,723,363, compared to $1,840,371 in the same period of 2023.
• The company's gross profit increased to $2,210,266, with a gross profit margin of 81%, up from 73% in the prior year.
• However, the company's net loss widened to $4,722,970, compared to a net loss of $1,689,034 in the first quarter of 2023.
• The net loss attributable to common stockholders was $5,170,970, or $0.51 per share, compared to $1,689,034, or $0.26 per share, in the prior year.
• Operating expenses increased significantly to $5,252,451, driven by higher selling, general, and administrative costs, as well as increased depreciation and amortization.
• The company's cash balance decreased to $138,031 as of March 31, 2024, from $1,219,358 at the end of 2023.
• The company has a working capital deficit of $10,906,674 and an accumulated deficit of $120,209,729.
• The company acquired assets from FeatherPay, Verifi Dental, and Teamworx in January 2024, which contributed to revenue growth but also increased expenses.
• The company is reliant on future fundraising to finance operations and has stated there is substantial doubt about its ability to continue as a going concern.

Sentiment

Score: 3

Explanation: While the company shows strong revenue growth, the significant net loss, cash burn, and going concern warning create a negative outlook. The company's reliance on future funding and material weaknesses in internal controls further contribute to the low sentiment score.

Positives

• The company achieved a significant 48% increase in revenue year-over-year.
• Gross profit margin improved from 73% to 81%, indicating better cost management.
• The company successfully completed several asset acquisitions, expanding its product offerings.
• The company continues to see organic growth in its SaaS based products.

Negatives

• The company's net loss widened significantly to $4,722,970.
• Operating expenses increased substantially, outpacing revenue growth.
• The company's cash balance decreased significantly to $138,031.
• The company has a substantial working capital deficit of $10,906,674.
• The company has an accumulated deficit of $120,209,729.
• The company is reliant on future fundraising to finance operations.
• There is substantial doubt about the company's ability to continue as a going concern.

Risks

• The company's ability to continue as a going concern is in doubt due to its substantial losses and reliance on future funding.
• The company's high operating expenses are outpacing revenue growth, leading to increased losses.
• The company's low cash balance poses a significant risk to its ability to fund operations.
• The company's reliance on future fundraising creates uncertainty about its financial stability.
• The integration of recent acquisitions may present challenges and risks.
• The company has identified material weaknesses in its internal control over financial reporting.

Future Outlook

The company intends to raise additional capital through the issuance of debt and/or equity securities to fund its operations. Management intends to develop an improved healthcare communications system and intends to develop alliances with strategic partners to generate revenues that will sustain the Company. The company is reliant on future fundraising to finance operations in the near future and there is substantial doubt about its ability to continue as a going concern.

Management Comments

• Management believes in the viability of its strategy to increase revenues and in its ability to raise additional funds.
• Management's ability to continue as a going concern is ultimately dependent upon its ability to continually increase the Company's customer base and realize increased revenues from signed contracts.

Industry Context

The company operates in the cloud-based software and technology sector, focusing on healthcare workflow productivity. The company is benefiting from the trend towards cloud-based SaaS offerings. The company is competing with other companies offering similar SaaS solutions in the healthcare industry.

Comparison to Industry Standards

• The company's 48% revenue growth is strong compared to some industry peers, but the significant net loss and cash burn are concerning.
• The company's gross margin of 81% is competitive, but its operating expenses are high compared to industry benchmarks.
• The company's reliance on external funding is a common challenge for early-stage SaaS companies, but the stated doubt about its ability to continue as a going concern is a significant concern.
• The company's financial performance is not directly comparable to established, profitable SaaS companies, but it is important to compare its growth rate and margins to other early-stage companies in the healthcare SaaS space.
• The company's acquisitions are a common strategy for growth in the SaaS industry, but the integration risks and costs need to be carefully managed.

Legal Proceedings

• The company is involved in a dispute with a service provider, with claimed damages of approximately $635,000.

Related Party Transactions

• The company entered into several promissory notes and convertible notes with related parties.

Stakeholder Impact

• Shareholders face significant risk due to the company's substantial losses and going concern warning.
• Employees may be impacted by potential downsizing or operational changes if the company fails to secure additional funding.
• Customers may be affected by potential disruptions in service if the company's financial situation deteriorates.
• Creditors face increased risk due to the company's financial instability.

Next Steps

• The company intends to raise additional capital through the issuance of debt and/or equity securities.
• The company plans to develop an improved healthcare communications system.
• The company intends to develop alliances with strategic partners to generate revenues.
• The company will need to address the material weaknesses in its internal control over financial reporting.
• The company will need to seek shareholder approval for certain proposals at the 2024 Annual Meeting to be held on May 31, 2024.

Key Dates

Keywords

SaaS, revenue, net loss, acquisitions, software, healthcare, financial results, operating expenses, debt, capital raise